If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Income 1 Regulatory News (MIG1)

Share Price Information for Maven Income 1 (MIG1)

Share Price is delayed by 15 minutes
Get Live Data
33.80    0.00 (0.00%)
Bid:
32.80
Ask:
34.80
Spread: 2.00 (6.098%)
Market Cap: £70.16m
MIG1 Live PriceLast checked at - London Stock Exchange

Intraday Maven Income 1 Share Chart

Statement re Offers for Subscription

30 Jan 2015 16:53

RNS Number : 6776D
Maven Income and Growth VCT 3 PLC
30 January 2015
 



Joint Announcement

 

Offers for Subscription - Maven VCT 3 Offer Fully Subscribed

 

Maven Income and Growth VCT plc ("Maven VCT 1"), Maven Income and Growth VCT 2 plc ("Maven VCT 2"), Maven Income and Growth VCT 3 plc ("Maven VCT 3"), Maven Income and Growth VCT 4 plc ("Maven VCT 4") and Maven Income and Growth VCT 5 plc ("Maven VCT 5") (together "the Companies" and each a "Company") are managed by Maven Capital Partners UK LLP ("Maven").

 

The Boards of the Companies launched offers for subscription to raise, in aggregate, up to £18 million ("the Offers" and each an "Offer"). Full details of the Offers are contained in a prospectus ("the Prospectus"), which was published by the Companies on 20 October 2014.

 

Further to the announcements of 7 and 20 January 2015 that the respective Offers by Maven VCT 4 and Maven VCT 1 were closed for further applications, the Companies are pleased to announce that applications have now been received for the full amount available under the Maven VCT 3 Offer and, as such, the Maven VCT 3 Offer is now also closed for further applications. Prospective investors can still apply to invest amounts of their choice in one or both of the remaining Offers (Maven VCT 2 and Maven VCT 5) or invest an equal amount in each of those Companies, and the amount subscribed under each remaining Offer will be invested in new ordinary shares of 10p each in the relevant Company.

 

The remaining Offers will close at 12.00 noon on 28 April 2015 (unless fully subscribed by an earlier date or otherwise extended or closed at the Directors' discretion). Persons intending to apply under the remaining Offers for the 2014/2015 tax year should note that the deadline for such applications is 12.00 noon on 1 April 2015.

 

The Prospectus was submitted to the Financial Conduct Authority and copies of the Prospectus are available for download from the Companies' websites:

 

· www.mavencp.com/migvct

· www.mavencp.com/migvct2

· www.mavencp.com/migvct3

· www.mavencp.com/migvct4

· www.mavencp.com/migvct5

 

and from the National Storage Mechanism (http://www.hemscott.com/nsm.do). For further information, please contact:

 

Maven Capital Partners UK LLP

Telephone: 0141 306 7400

E-mail: enquiries@mavencp.com

 

Maven Capital Partners UK LLP

Secretary

30 January 2015

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRQBLFXEFFEBBL
Date   Source Headline
6th Jul 20234:01 pmRNSStatement re Intended Offers for Subscription
6th Jul 20233:37 pmRNSNet Asset Value
6th Jul 20231:06 pmRNSResult of AGM
7th Jun 20234:21 pmRNSAnnual Financial Report
2nd Jun 20239:39 amRNSIssue of Equity
1st Jun 202312:18 pmRNSNet Asset Value(s)
26th May 20233:53 pmRNSTransaction in Own Shares
24th May 202310:52 amRNSUnaudited NAV and Proposed Final Dividend
27th Apr 20231:04 pmRNSIssue of Supplementary Prospectus
5th Apr 202312:33 pmRNSDirector/PDMR Shareholding
5th Apr 202312:26 pmRNSIssue of Equity
29th Mar 20232:19 pmRNSIssue of Supplementary Prospectus
3rd Mar 202310:37 amRNSDirector/PDMR Shareholding
3rd Mar 202310:35 amRNSDirector/PDMR Shareholding
3rd Mar 202310:35 amRNSDirector/PDMR Shareholding
3rd Mar 20239:47 amRNSIssue of Equity
21st Feb 20234:39 pmRNSTransaction in Own Shares
6th Feb 20234:23 pmRNSNet Asset Value(s)
2nd Dec 20229:30 amRNSIssue of Equity
25th Nov 202212:36 pmRNSStatement re Dividend Investment Scheme
9th Nov 20222:34 pmRNSResult of General Meeting
4th Nov 202211:15 amRNSHalf-year Report
26th Oct 20223:50 pmRNSTransaction in Own Shares
14th Oct 20223:33 pmRNSNet Asset Value and Interim Dividend
7th Oct 20224:28 pmRNSPublication of a Prospectus
4th Oct 20223:30 pmRNSChange of Auditor
5th Aug 20224:39 pmRNSTransaction in Own Shares
15th Jul 202211:08 amRNSIssue of Equity
11th Jul 20223:12 pmRNSStatement re Dividend Investment Scheme
8th Jul 20223:28 pmRNSStatement re Joint Offers for Subscription
8th Jul 20222:36 pmRNSNet Asset Value(s)
7th Jul 20222:34 pmRNSResult of AGM
8th Jun 20222:12 pmRNSAnnual Financial Report
29th Apr 20222:28 pmRNSTransaction in Own Shares
27th Apr 20224:04 pmRNSTransaction in Own Shares
21st Apr 202211:22 amRNSStatement re NAV and Proposed Final Dividend
25th Jan 20224:04 pmRNSTransaction in Own Shares
21st Jan 20223:15 pmRNSNet Asset Value(s)
3rd Dec 20219:48 amRNSIssue of Equity
26th Nov 20219:53 amRNSStatement re Dividend Investment Scheme
12th Nov 20214:31 pmRNSHalf-year Report
11th Nov 20214:23 pmRNSTransaction in Own Shares
9th Nov 20211:33 pmRNSTransaction in Own Shares
27th Oct 20214:44 pmRNSNet Asset Value and Interim Dividend
20th Sep 20214:57 pmRNSStatement re Change of Registrar
16th Jul 202110:04 amRNSIssue of Equity
12th Jul 20214:28 pmRNSStatement re Dividend Investment Scheme
7th Jul 20213:32 pmRNSNet Asset Value(s)
7th Jul 202112:37 pmRNSResult of AGM
4th Jun 20214:16 pmRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.